Among the comprehensive assessments employing diverse criteria for all variables from the LIHC dataset, PRMT1 has emerged as a promising prognostic biomarker, exhibiting consistent correlations with HCC. This evidence concerns the gene PRMT1 and hepatocellular carcinoma.